This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Yara International Asa
10/25/2024
Welcome to Java's third quarter results presentation. The presentation today will be held by our CEO, Svein-Tore Holsetter, and our CFO, Tor Eber. There'll be a conference call at 1 p.m. Oslo time, where you can dial in and ask questions. Login details are found under the investor page on java.com. And with that, it's my pleasure to hand over to Svein-Tore Holsetter.
Thank you, Maria, and good morning, good afternoon, and good evening, depending on where you're dialing in from, and thank you for joining the JARA third quarter results presentation. As always, we start by looking at our safety performance, and our TRI has continued to decline over the last six months. In general, the severity of the accidents have been low in the third quarter, but still, this year, we have experienced serious near misses. And this is a very clear reminder of how critical it is that we keep enforcing a strict focus on safety every day. I want to give credit to all my colleagues for the Safe by Choice way of working. It has really made a difference, and we are progressing towards zero injuries. Turning then to the main elements of the quarter. EBTA, excluding special items, is $585 million for the quarter. with improved margins compared to a year earlier. While commodity nitrogen margins have been stable to slightly negative, we have delivered strong NPK margins this quarter, primarily due to improved P and also K pricing. NPKs and other premium products are at the very core of our operations and deliver strong premiums above commodity pricing. We're also pleased to deliver all time high production for both ammonia and finished fertilizers. And this is an especially strong performance following a period where we have and where we are running our plants on suboptimal raw materials mix. with many startups and shutdowns and experimenting with different levels of utilization. And I believe that this clearly shows the resilience of our assets and even more so our workforce. It's a clear demonstration of the strength of a purpose driven company. This also improves our ability to deliver products and returns in the coming quarters. Our earnings and returns are on an improving trend. However, we are still below our through the cycle target of 10%. Therefore, we continue to focus on cost and portfolio optimization. Looking then at the EBITDA variance for the quarter, the main factors improving our earnings are increased margins and lower fixed costs. The margin increase is mainly driven by improved phosphate upgrading margins, more stable potash pricing, and improved commercial margins in Brazil. Fixed costs are $36 million lower than last year, partly reflecting one-off items, but also $14 million of sustainable improvement, including divestments. Volumes are down approximately 4% compared to last year, however, with a limited financial impact due to positive mixed effects, mainly consisting of increased ammonia production and deliveries at good margins. With this, the return on invested capital for the quarter in isolation shows a strong improvement from last year, going from 3.6% to 8.9%. As mentioned, production for the quarter has been strong. Actual production for ammonia and finished goods is up 14% and 8% respectively for the last 12 months compared with 2023. Production performance were Volumes lost for major plant maintenance and market-driven curtailments are added back. And then they are at an all-time high with 8 million tons of ammonia and 21.1 million tons of finished fertilizers produced in the last 12 months. The most profitable and strategically important sites have driven most of the improvement. And let me give a few examples. Porsgrunn MPK has set a new monthly production record nine months in a row, leading to more than $30 million improvement on an annual basis. Bellplane continues to deliver strong performance, where both ammonia and urea are running above recent years' performance with excellent reliability and margins. This gives us comfort in the robustness of our production system, even with multiple curtailments, plant stop and starts, and our plants are able to run at strong levels. Our production plants are really the backbone of our business, and improving the output of our plants reduces the production cost per ton, and it also improves returns. I'll now hand over to Tor to take us through the financials. So over to you, Tor.
So as you've already seen, we have a strong EBITDA this quarter, up 47%, mainly due to improved margins. The earnings per share increase was even stronger as it was positively impacted by a currency gain of $113 million, while last year we had a currency loss of $65 million. Net operating capital is negative for the quarter, but for positive reasons, reflecting both higher production and increasing margins. Last year we had a significant release of operating capital, mainly due to significant price declines in the first half of 2024. The reduction in cash from operations is more than explained by operating capital developments, with stronger operating cash flow offsetting some of the operating capital increase. Investments are lower, mainly reflecting that last year we had major maintenance in our Pilbara plant in Australia. And as you've already seen, ROIC was 8.9 for the quarter in isolation, and on a 12-month rolling basis, it was 6.9%, reflecting a positive trend given the quarter return, a positive trend in our financial performance. Now let's take a look at our margin improvement, which this quarter comes despite lower nitrogen margins in the market overall. Firstly, nitrate and NPK premiums generated in recent quarters are strong, above the five-year average, which includes a very strong period in 2022 and early 2023. We also have a significantly improved phosphate upgrading margin, which was almost zero last year due to low DAP prices and high phosphate rock prices. Well, this year the situation has reversed and overall margins are closer to average. The improved phosphate margins represent approximately $50 million positive EBITDA effect this quarter. Potash prices were on a downward trend this time last year, compressing NPK margins as we have a time lag typically of around three months from sourcing MOP to delivering NPK. The MOP price is more stable this year, generating a positive impact of approximately $20 million in the quarter. In Brazil, Yara focuses on premium over volume and uses third-party volumes to balance out supply versus demand. Last year, the margins on these third-party products were negative, while they've rebounded to more than $40 per tonne this year. We delivered approximately 1.1 million tonnes of these third-party volumes in Brazil this quarter, slightly down from 1.2 million tonnes one year ago. And this gives a positive impact of this margin improvement, gives a positive impact of approximately $50 million EBITDA in the quarter. Let's take a look at the status of our cost and capex reduction program, which we announced in the second quarter. For the past 12 months, fixed costs are down approximately $45 million or $36 million excluding currency effects. $14 million of this variance is sustainable and includes the divestment of Yara Marine in addition to first wave savings on external cost and other immediately available actions across the organization. The remainder of the $36 million is a combination of one-offs and normal variations which we will not count towards our target of $150 million cost reduction by the end of 2025. The second wave of the cost project focusing on targeted structural actions is under development with execution starting in first quarter 2025. The main target realization is therefore expected during the second half of next year. And in the meantime, we'll have inflation effects and normal variations. So do not draw a straight line from our last 12 months performance to the end 2025 run rate target. CAPEX is progressing as planned and in line with our updated guidance. And the fixed cost and capex reduction program is a top priority for the organization and is one part of several actions to future-proof core operations and increase shareholder returns, which Svein Tuide will summarize later in the presentation. Turning now to deliveries, we had a decline in total of 4% compared to the same quarter last year. Crop nutrition deliveries fell 7%, and this was mainly within commodity product deliveries. In Brazil, the third-party product deliveries decreased by approximately 140 kilotons, as mentioned as we prioritized margins over volume. In Europe, deliveries were 8% down, mainly reflecting limited commodity product pre-buying in Southern Europe. In Africa and Asia, deliveries were down also due to margin over volume focus and also some phasing effects in certain markets. Industrial deliveries were stable compared with last year, but lower than historical average, reflecting mainly a reduced industrial activity in Europe. Finally, ammonia deliveries increased 56%, reflecting strong ammonia production performance in the quarter. Looking at the segment results for the quarter, we have improved earnings and returns in all segments except for Europe. The combination of high energy costs, increased competition from imports, and an ambitious regulatory environment is highly challenging for the European fertilizer industry. However, Yara is well-placed to mitigate these challenges over time through cost reduction, portfolio management, and utilizing our global ammonia sourcing flexibility. In Americas, the improvements mainly reflect improved commercial margins and positive currency impact. In Africa and Asia, we saw higher margins in Asia and Asia Pacific, and last year was impacted by downtime in Pilbara, Australia. In global plants, results increased due to higher production volume and improved margins. And in clean ammonia, the results were up $19 million, driven by higher volumes, thanks to improved ammonia production. Our net debt is roughly stable compared to last quarter, as improved cash earnings funded both investments and the operating capital increase in the quarter. And this brings our net debt to equity ratio and net debt to EBITDA ratio to respectively 47% and 1.71%, both of which are within our financial policy range. Turning now to our integrated scorecard, most of the profit metrics have been covered already in the presentation. For our people and planet KPIs, we continue to see an overall positive trend. GHG intensity is at a record low level of 2.9 CO2 equivalents per tonne of nitrogen produced, and this is on track to reach our target of 2.7 next year. The investments generating this improvement are profitable with an average payback period of three years. Absolute GHG emissions are up compared to 2023 due to higher production rates. The operating capital days increase is mainly due to higher inventory levels following high production rates and seasonally lower deliveries. And finally, our top priority is the cost and capex program and portfolio optimization to sustainably improve our returns. Before I hand back to Svein Tordur, let's take a look at the fundamentals for the nitrogen market. Nitrogen prices are demand-driven with prices above historical averages and reflecting a tight global market balance. There are two main factors impacting 2024, and these are Indian imports and Chinese exports. Chinese exports have been close to zero so far in 2024, and this trend is expected also for the rest of the year. Supply growth elsewhere is also close to zero, as you can see. However, the demand side is also weaker this year, mainly due to lower Indian imports, following strong domestic production and inventory building ahead of the election earlier this year. We can expect further declines both on the supply side and demand side in the second half of this year, as last year China exported more than 3 million tonnes and India imported more than 5.5 million tonnes. Looking beyond this year, with limited urea capacity additions in the pipeline, we expect nitrogen markets to tighten further. Chinese export policy remains a key factor to monitor also going forward, with recently increased domestic consumption and lower exports a clear positive. With that, I'll now hand you back to Svein Tore for his closing remarks.
Thank you, Tor. As mentioned, portfolio optimization is at the top of our agenda, and I want to be very clear on how we review and manage our portfolio decisions. Any evaluation of our portfolio is exclusively driven by long-term returns. And the first step is to divest or optimize low-return and non-core assets. We've already made some progress here, divesting smaller market operations, such as Cameroon and Ivory Coast. And we've also divested non-core businesses, such as Yara Marine and a terminal in North America, and our liquid NPK business in Brazil. In terms of production portfolio optimization, we are in the process of repurposing our Montoir plant in France, and last week we announced an intention to transform our territory site in belgium we're continuing to work on our plant prioritization framework and progress our company-wide asset portfolio review secondly Being a large competitive industry player and an attractive partner, Yara has a strong pipeline of potential growth projects. Here we are disciplined in only focusing on projects with a clear strategic fit, future competitiveness, and strong shareholder returns. We explore a number of projects and do not proceed when we do not see strong returns and strategic fit. A good example of this is that our completed greenhouse gas projects, which have been with an average payback period of three years, as Tor already mentioned. Examples of projects we've shelved are green hydrogen projects in Porsgrunn and Sløyskull, both with renewable ammonia, but without attractive returns, and both managed without material losses. However, where we do see strong potential, there we progress. And our current focus is U.S. upstream ammonia projects. The profitability of these is expected to be strong and with a very clear strategic fit to Yara's competitive edge and business model. The U.S. ammonia projects can complement JAA's existing ammonia midstream position and our European premium production setup. First, our ammonia system is the world's largest and fully scalable. Secondly, as EU carbon pricing increases, nitrogen pricing in Europe, nitrate and NPK margins will increase when upgraded from low carbon ammonia. As all of Yara's nitrate and NPK production can run on imported ammonia, we can achieve a low carbon premium by importing ammonia. In addition, we see further margin potential by having an upstream position in U.S. ammonia. Upgrading margin from gas to ammonia is an important element of JARA's upstream margins. By switching to production in the U.S., we get access to competitive gas pricing and also well-advanced CCS infrastructure. Furthermore, with the large scale, we can significantly reduce our capex per ton. And most importantly, we have offtake for these volumes internally from our European premium product plants. And in addition to growing external demand from new clean ammonia markets. The combination of these is expected to provide Jara with strong shareholder returns and also support a fit for future, yada. And let me be clear, we will not sanction these projects if we do not see double digit returns. To summarize, as mentioned, the key focus of the whole organization is now to optimize our core operations to increase free cash flow and generate high returns in order to fund shareholder returns and value accretive growth. We're making progress across all key elements. Our third quarter earnings are showing improved returns and also lower fixed costs. We're continuing to evaluate and refocus our portfolio, and the two largest projects announced are the repurposing of Montevall and also the intention to transform the title site. For the upstream ammonia projects, we are continuing to mature the products and evaluating the most value accretive path to a low cost and low emission ammonia portfolio. We continue to see strong premiums and are actively optimizing volumes based on premiums, especially in Brazil and Europe. Nitrogen market fundamentals are improving with further tightening expected in the coming years. Summarizing, we are very much on the right track to refocus our company to core operations and value-creative growth. And this will support a future-proof JARA with sustainable earnings and increased shareholder returns. I will now hand back to Maria. Over to you.
Thank you, Svein Tore. I'd just like to give you all a final reminder that you have the opportunity to ask questions in the conference call starting at 1 p.m. Oslo time. And that concludes today's presentation. Thank you for watching.